These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19463883)

  • 1. Zaleplon increases nocturnal melatonin secretion in humans.
    Morera AL; Abreu-Gonzalez P; Henry M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1013-6. PubMed ID: 19463883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
    Stone BM; Turner C; Mills SL; Paty I; Patat A; Darwish M; Danjou P
    Br J Clin Pharmacol; 2002 Feb; 53(2):196-202. PubMed ID: 11851645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep-inducing pharmaceuticals: a comparison of melatonin, zaleplon, zopiclone, and temazepam.
    Paul MA; Gray G; MacLellan M; Pigeau RA
    Aviat Space Environ Med; 2004 Jun; 75(6):512-9. PubMed ID: 15198277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R; Rüther E; Farr I; Emilien G; Salinas E
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group.
    Fry J; Scharf M; Mangano R; Fujimori M
    Int Clin Psychopharmacol; 2000 May; 15(3):141-52. PubMed ID: 10870872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of zaleplon, a non-benzodiazepine hypnotic, on melatonin secretion in rabbits.
    Noguchi H; Kitazumi K; Mori M; Shiobara Y; Shiba T
    J Pharmacol Sci; 2003 Oct; 93(2):204-9. PubMed ID: 14578589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance.
    Paul MA; Gray G; Kenny G; Pigeau RA
    Aviat Space Environ Med; 2003 Dec; 74(12):1263-70. PubMed ID: 14692469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trazodone hypnotic effect and nocturnal melatonin secretion.
    Morera AL; Abreu-Gonzalez P; Henry M; Garcia-Hernandez A
    J Clin Psychopharmacol; 2009 Feb; 29(1):97-9. PubMed ID: 19142123
    [No Abstract]   [Full Text] [Related]  

  • 9. Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia.
    Hajak G; Rodenbeck A; Adler L; Huether G; Bandelow B; Herrendorf G; Staedt J; Rüther E
    Pharmacopsychiatry; 1996 Sep; 29(5):187-92. PubMed ID: 8895944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
    Zammit GK; Corser B; Doghramji K; Fry JM; James S; Krystal A; Mangano RM
    J Clin Sleep Med; 2006 Oct; 2(4):417-23. PubMed ID: 17557470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg.
    Allain H; Bentué-Ferrer D; Breton SL; Polard E; Gandon JM
    Hum Psychopharmacol; 2003 Jul; 18(5):369-74. PubMed ID: 12858323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin as a hypnotic: pro.
    Zhdanova IV
    Sleep Med Rev; 2005 Feb; 9(1):51-65. PubMed ID: 15649738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term use of sedative hypnotics in older patients with insomnia.
    Ancoli-Israel S; Richardson GS; Mangano RM; Jenkins L; Hall P; Jones WS
    Sleep Med; 2005 Mar; 6(2):107-13. PubMed ID: 15716214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zaleplon: a review of its use in the treatment of insomnia.
    Dooley M; Plosker GL
    Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypnotic efficacy of zaleplon for daytime sleep in rested individuals.
    Whitmore JN; Fischer JR; Storm WF
    Sleep; 2004 Aug; 27(5):895-8. PubMed ID: 15453547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia.
    Walsh JK; Pollak CP; Scharf MB; Schweitzer PK; Vogel GW
    Clin Neuropharmacol; 2000; 23(1):17-21. PubMed ID: 10682226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group.
    Hedner J; Yaeche R; Emilien G; Farr I; Salinas E
    Int J Geriatr Psychiatry; 2000 Aug; 15(8):704-12. PubMed ID: 10960882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocturnal melatonin secretion and its modification by treatment in patients with sleep disorders.
    Rodenbeck A; Huether G; Rüther E; Hajak G
    Adv Exp Med Biol; 1999; 467():89-93. PubMed ID: 10721043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharma-clinics. Drug of the month. Zaleplon (Sonata)].
    Ansseau M
    Rev Med Liege; 1999 Aug; 54(8):705-6. PubMed ID: 10548901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of zolpidem and zaleplon on cognitive performance after emergent morning awakenings at Tmax: a randomized placebo-controlled trial.
    Dinges DF; Basner M; Ecker AJ; Baskin P; Johnston SL
    Sleep; 2019 Mar; 42(3):. PubMed ID: 30576525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.